Letters

Harm resulting from screening is likely to be high where prevalence of breast cancer is low

BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7101.190 (Published 19 July 1997) Cite this as: BMJ 1997;315:190
  1. Peymane Adab, Lecturer in public health medicinea
  1. a Department of Community Medicine, University of Hong Kong, Hong Kong

    Editor—Matti Hakama and colleagues evaluated an organised programme of screening for breast cancer in Finland.1 They report a 24% reduction in mortality from breast cancer due to screening, which, as they point out, is close to the protective effect reported in the early randomised controlled trials. In their …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe